PeptideScanner retained ClinicalTrials.gov record NCT02125188 at 2026-11-16T01:33:21.554Z. Its registry update date was 2017-06-06, and PeptideScanner's reviewed identity mapping was desmopressin. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1